FAF
ALXN

Första AP-fonden’s Alexion Pharmaceuticals ALXN Stock Holding History

Första AP-fonden’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-51,800
Closed -$9.52M – 585
2021
Q2 		$9.52M Buy
51,800
+6,800
+15% +$1.17M 0.11% 214
2021
Q1 		$6.88M Sell
45,000
-10,100
-18% -$1.56M 0.1% 251
2020
Q4 		$8.61M Buy
55,100
+13,000
+31% +$1.67M 0.13% 174
2020
Q3 		$4.82M Buy
42,100
+14,900
+55% +$1.61M 0.1% 221
2020
Q2 		$3.05M Buy
27,200
+2,100
+8% +$223K 0.08% 271
2020
Q1 		$2.25M Buy
+25,100
New +$2.46M 0.08% 293

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Första AP-fonden's ALXN Position: Q3 2021 in Review

Första AP-fonden sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 51,800 shares — an estimated $9.52M sold.

Första AP-fonden first reported a position in ALXN in Q1 2020 and held it in 6 quarters. The position peaked at $9.52M in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Första AP-fonden reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Första AP-fonden sold 51,800 Alexion Pharmaceuticals shares in Q3 2021, an estimated $9.52M.
  • Första AP-fonden first reported a position in Alexion Pharmaceuticals in Q1 2020 and held it in 6 quarters.
  • Första AP-fonden's Alexion Pharmaceuticals position peaked at $9.52M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Första AP-fonden's 13F filing for Q3 2021, filed 10 Nov 2021.